These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nesiritide - not verified. Topol EJ N Engl J Med; 2005 Jul; 353(2):113-6. PubMed ID: 16014879 [No Abstract] [Full Text] [Related]
3. The lost decade of nesiritide. Topol EJ N Engl J Med; 2011 Jul; 365(1):81-2. PubMed ID: 21732841 [No Abstract] [Full Text] [Related]
4. The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Kesselheim AS; Fischer MA; Avorn J Health Aff (Millwood); 2006; 25(4):1095-102. PubMed ID: 16835191 [TBL] [Abstract][Full Text] [Related]
6. Nesiritide: the wrong controversy. Somberg JC Am J Ther; 2005; 12(5):377-8. PubMed ID: 16148421 [No Abstract] [Full Text] [Related]
7. Benefits, risks of heart failure drug questioned. The jury is still out on who needs nesiritide, a new heart failure drug, as well as what its risks are. Harv Heart Lett; 2005 Aug; 15(12):3. PubMed ID: 16200669 [No Abstract] [Full Text] [Related]
8. [Does nesiritide reduce dyspnea in decompensated heart failure?]. Bernardo WM; Moreira FT Rev Assoc Med Bras (1992); 2012; 58(1):11-3. PubMed ID: 22392308 [No Abstract] [Full Text] [Related]
9. Re: Critical review and recommendations for nesiritide use in the Emergency Department. Levine M J Emerg Med; 2007 Feb; 32(2):207-8; author reply 208-9. PubMed ID: 17307636 [No Abstract] [Full Text] [Related]
10. [Nesiritide in heart failure: commercial success or therapeutic advance?]. Stampfli T; Perrier A Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047 [TBL] [Abstract][Full Text] [Related]
11. Impact of nesiritide on renal function and mortality in patients suffering from heart failure. Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976 [TBL] [Abstract][Full Text] [Related]
12. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Munger MA; Ng TM; Van Tassell BW Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695 [TBL] [Abstract][Full Text] [Related]
13. In brief: nesiritide (Natrecor). Med Lett Drugs Ther; 2011 Nov; 53(1377):92. PubMed ID: 22089926 [No Abstract] [Full Text] [Related]
14. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
15. Observation unit treatment of heart failure with nesiritide: results from the proaction trial. Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of nesiritide in patients with acute decompensated heart failure. DeWald TA; Hernandez AF Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602 [TBL] [Abstract][Full Text] [Related]
17. Risk of death with nesiritide. Burger AJ JAMA; 2005 Aug; 294(8):897; author reply 898. PubMed ID: 16118377 [No Abstract] [Full Text] [Related]
18. Risk of death associated with nesiritide in patients with acutely decompensated heart failure. Aaronson KD; Sackner-Bernstein J JAMA; 2006 Sep; 296(12):1465-6. PubMed ID: 17003394 [No Abstract] [Full Text] [Related]
19. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide. Noviasky JA Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696 [TBL] [Abstract][Full Text] [Related]